Background illustration for clinical trials search

Paid Clinical Trials Arizona

Discover 1,569 paid clinical trials in Arizona. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Development and Validation of Advanced MRI Methods for Clinical Applications

for
Brain Tumor
Location: Phoenix AZ
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT03264300

Recruiting

SynCardia 70cc TAH-t for Destination Therapy (DT)

for
Life-threatening, Biventricular Heart Failure,
Location: Richmond VA, Milwaukee WI, Houston TX, Oklahoma City OK,
Sponsor: SynCardia Systems. LLC

Sex: All

Age: 19+

Code: NCT02232659

Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Norwich CT, Hackensack NJ, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

for
Burns
Location: Washington D.C. DC, Iowa City IA, Phoenix AZ,
Sponsor: Skingenix, Inc.

Sex: All

Age: 18+

Code: NCT01297400

Phase2, Recruiting

The Oxford Risk Factors And Non-Invasive Imaging Study

for
Cardiovascular Diseases, Cardiovascular Risk Factors
Location: Boston MA, New Haven CT, Bethesda MD,
Sponsor: University of Oxford

Sex: All

Age: 18 - 70+

Code: NCT05169333

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,
Location: Boston MA, Stony Brook NY, New York NY, Burlington VT,
Sponsor: Endotronix, Inc.

Sex: All

Age: 18+

Code: NCT05934487

Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients

for
Non-Small Cell Lung Cancer
Location: Burlington MA, Hartford CT, New Haven CT, Lebanon NH,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT05899608

Phase3, Recruiting

5-ALA in Recurrent Glioma

for
Glioma
Location: Phoenix AZ
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix

Sex: All

Age: 18+

Code: NCT02119338

Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Plymouth MA, Boston MA, The Bronx NY, New York NY,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase2, Recruiting

Randomized Controlled Trial Comparing Standard Versus Positive Pressure Nebulization in Infants With Bronchiolitis to Reduce Hospital Admissions

for
Bronchiolitis
Location: Phoenix AZ
Sponsor: Phoenix Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT01229384

Recruiting

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

for
Tricuspid Regurgitation
Location: Lebanon NH, The Bronx NY, Cleveland OH, Atlanta GA,
Sponsor: Laplace Interventional, Inc

Sex: All

Age: 18 - 70+

Code: NCT06183684

Recruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: Bristol CT, New Hyde Park NY, New York NY, Danville PA,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05530343

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Lebanon NH, New Hyde Park NY, Neptune City NJ,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

SPIROMICS Study of Early COPD Progression (SOURCE)

for
COPD, Early-Onset
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: University of Massachusetts, Worcester

Sex: All

Age: 30 - 55

Code: NCT05033990

Recruiting

tDCS and Impulsivity

for
Substance Use Disorders, Substance Abuse, Substance Use
Location: Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT05845164

Recruiting

Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors, Metastatic Solid Tumors
Location: Scottsdale AZ
Sponsor: Trutino Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06770764

Phase1, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Boston MA, Worcester MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fairhaven MA, Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06129864

Phase3, Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, Westbury NY, New York NY, Washington D.C. DC,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06162221

Phase1, Phase2, Recruiting

Popular cities in Arizona

With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.

Why choose Arizona for clinical trials?

Participating in clinical trials in Arizona offers several unique advantages. First, due to the state being home to some of the nation's top research institutions, participants have access to cutting-edge treatments and advanced medical care. These institutions are leaders in fields like oncology, cardiology, and precision medicine, allowing participants to be at the forefront of groundbreaking medical advancements.

Another significant advantage is Arizona's diverse population, which allows for a broad range of clinical trials addressing different demographics and health conditions. This diversity increases the relevance of clinical trial outcomes across varied populations, ensuring more accurate and inclusive medical research. Additionally, Arizona’s pleasant climate and growing healthcare infrastructure make participation in trials more convenient and accessible, especially for those traveling to Phoenix or Tucson for care.

Common conditions studied in Arizona

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Arizona